跳到正文
研踪PaperTrail
← 研踪 PaperTrail

arXiv:2610.37353 · v1

Cost-based variable selection for prediction models

首次提交 2026-10-27 22:54
版本更新 2026-10-27 22:54
雷达观测 2026-10-29 01:06
arXiv ↗PDF ↗

摘要

Objective: Variable selection for clinical prediction models is commonly done on statistical grounds related to model fit. Statistical approaches ignore the cost of misclassifications and the harm of measuring a variable. We aim to develop a decision-analytic variable selection algorithm based on net benefit. Materials and Methods: The proposed algorithm selects the set of predictors by exhaustively comparing the net benefit of all combinations using cross validation, with an extension based on backward elimination for settings with many predictors. Variables are selected if the increased net benefit from better predictiveness exceeds the net benefit reduction from the harm of variable measurement. Harm includes financial expense, time, resource allocation, and patient burden. We illustrate the algorithm through a simulated example and three real case studies. We compare its performance to traditional backward elimination and LASSO. Results: Across the case studies, parsimonious models were generated that optimized clinical utility with minimal impact on discrimination and calibration. Penalizing predictors based on their cost ensured that expensive or burdensome variables were only selected if they offer sufficient clinical utility. The algorithm was implemented in the R package NBvarsel. Discussion: Decision-analytic variable selection allows prediction models to maximize patient benefit while minimizing unnecessary clinical burden and costs. Conclusion: Clinical utility should not be an afterthought reserved only for implementation. By integrating a harm-adjusted net benefit metric directly into the variable selection process, NBvarsel allows researchers to select only the variables that sufficiently improve clinical utility.

作者备注:43 pages, 3 main figures, 4 main tables, 12 supplementary figures, 4 supplementary tables

AI 论文解读

基于摘要 · 非全文审阅

此版本尚未生成 AI 解读。解读由后台任务生成并按论文版本保存,登录后共享已有结果。

版本差异

目前只观测到一个版本,无法比较变化。之后收录新版本时,会在这里对照标题、作者、分类和摘要。

观测到的版本

相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。

v1 · 2026-10-27 22:54 · 最新观测版本

Cost-based variable selection for prediction models

Objective: Variable selection for clinical prediction models is commonly done on statistical grounds related to model fit. Statistical approaches ignore the cost of misclassifications and the harm of measuring a variable. We aim to develop a decision-analytic variable selection algorithm based on net benefit. Materials and Methods: The proposed algorithm selects the set of predictors by exhaustively comparing the net benefit of all combinations using cross validation, with an extension based on backward elimination for settings with many predictors. Variables are selected if the increased net benefit from better predictiveness exceeds the net benefit reduction from the harm of variable measurement. Harm includes financial expense, time, resource allocation, and patient burden. We illustrate the algorithm through a simulated example and three real case studies. We compare its performance to traditional backward elimination and LASSO. Results: Across the case studies, parsimonious models were generated that optimized clinical utility with minimal impact on discrimination and calibration. Penalizing predictors based on their cost ensured that expensive or burdensome variables were only selected if they offer sufficient clinical utility. The algorithm was implemented in the R package NBvarsel. Discussion: Decision-analytic variable selection allows prediction models to maximize patient benefit while minimizing unnecessary clinical burden and costs. Conclusion: Clinical utility should not be an afterthought reserved only for implementation. By integrating a harm-adjusted net benefit metric directly into the variable selection process, NBvarsel allows researchers to select only the variables that sufficiently improve clinical utility.

查看此版本解读 →查看此版本原文 ↗